Bruce Car
Fortuna: 745 542 $ al 31/05/2026
Fortuna: 745 542 $ al 31/05/2026
Bruce D.
Car is Chief Scientific Officer at Biohaven Ltd. since 2022.
Previously, Dr. Car was Chief Scientific Officer at Agios Pharmaceuticals, Inc. from 2020 to 2022.
Education includes a graduate degree from the University of Melbourne conferred in 1994 and a doctorate from Cornell University conferred in 1989.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOHAVEN LTD. 0,04 % | 03/03/2026 | 67.715 ( 0,04 % ) | 745 542 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOHAVEN LTD. | Director Técnico/Científico/I+D | 04/10/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/08/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Ltd.
Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.